Galderma Group AG Dividende 2027

GALD | CH1335392721 | SMI

Aktuelle Dividende 2025

Dividende
CHF 0.35
Aktienkurs
CHF 189.70
Rendite
0.18%
GV-Datum
-
Zahltag
-
Ex-Dividenden-Datum: 24.04.2026

Dividendenhistorie

Jahr Dividende Rendite +/- Vorjahr
2025 CHF 0.35 - +133.33%
2024 CHF 0.15 - -

Dividendenwachstum (CAGR)

3 Jahre -
5 Jahre -
10 Jahre -

Unternehmensdaten

Sektor Pharma
Index SMI
ISIN CH1335392721

Über Galderma Group AG

Galderma Group AG is a global healthcare company focused exclusively on dermatology, providing science-based products and services across injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its injectable aesthetics portfolio includes physician-administered neuromodulators and dermal fillers used in aesthetic clinics and medical practices. Dermatological skincare offerings include consumer and professional products for cleansing, moisturizing, skin protection, and the care of sensitive or problem-prone skin. Therapeutic dermatology products address conditions such as acne, rosacea, inflammatory skin disorders, and other common skin concerns through prescription and non-prescription treatments. The company serves healthcare professionals, patients, consumers, clinics, and retail channels, combining medical dermatology expertise with widely recognized skincare brands. Headquartered in Zug, Switzerland, Galderma Group AG occupies a specialized position in the healthcare market by connecting pharmaceutical treatments, physician-led aesthetic procedures, and everyday skincare within one dermatology-focused business. Its integrated portfolio supports diverse needs across medical, aesthetic, and consumer dermatology markets worldwide.